Article Text

Download PDFPDF

Multivalue ethical framework for fair global allocation of a COVID-19 vaccine
Free
  1. Yangzi Liu1,
  2. Sanjana Salwi1,
  3. Brian C Drolet2
  1. 1 School of Medicine, Vanderbilt University, Nashville, Tennessee, USA
  2. 2 Center for Biomedical Ethics and Society, Vanderbilt University Medical Center, Nashville, Tennessee, USA
  1. Correspondence to Ms Yangzi Liu, Vanderbilt University School of Medicine, Nashville, TN 37232, USA; yangzi.liu{at}vanderbilt.edu

Abstract

The urgent drive for vaccine development in the midst of the current COVID-19 pandemic has prompted public and private organisations to invest heavily in research and development of a COVID-19 vaccine. Organisations globally have affirmed the commitment of fair global access, but the means by which a successful vaccine can be mass produced and equitably distributed remains notably unanswered. Barriers for low-income countries include the inability to afford vaccines as well as inadequate resources to vaccinate, barriers that are exacerbated during a pandemic. Fair distribution of a pandemic vaccine is unlikely without a solid ethical framework for allocation. This piece analyses four allocation paradigms: ability to develop or purchase; reciprocity; ability to implement; and distributive justice, and synthesises their ethical considerations to develop an allocation model to fit the COVID-19 pandemic.

  • distributive justice
  • clinical ethics

This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.

https://bmj.com/coronavirus/usage

Statistics from Altmetric.com

Footnotes

  • Twitter @sanjanasalwi

  • Correction notice This paper has been updated since first published to amend name of

    'Brian C. Drolet'.

  • Contributors YL and SS contributed to research, analysis and writing of the manuscript. BD contributed to analysis, writing and critical review of the manuscript.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent for publication Not required.

  • Provenance and peer review Not commissioned; internally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Other content recommended for you